Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Microbot Medical Inc.

CIK 883975Updated Nov 18, 2026

Name history
Microbot Medical Inc. · through Nov 16, 2026STEMCELLS INC · through Nov 15, 2016CYTOTHERAPEUTICS INC/DE · through May 15, 2000

MBOT price & chart

Provider market data

Loading TradingView…

NASDAQ:MBOT on TradingView ↗

TradingView · Data may be delayed

About the company

Microbot Medical Inc. (NASDAQ: MBOT) is a pre-commercial stage medical technology company with a vision to improve the quality of care for millions of patients and providers globally. The Company has developed the world’s first single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. Further information about Microbot Medical® is available at http://www.microbotmedical.com.

8-K · 2025-04-01 · 0001641172-25-002002

Company description from the cited filing.

In the news

Seeking Alpha

Recent filings

  1. Regulation FD Disclosure

    Items 7.01, 9.01

    8-K · 2026-11-16 · 0001493152-26-052054

  2. 10-Q filing

    10-Q · 2026-11-13 · 0001493152-26-051756

  3. Regulation FD Disclosure · Other Events

    Items 7.01, 8.01, 9.01

    8-K · 2026-11-05 · 0001493152-26-050070

  4. ARS filing

    ARS · 2026-11-03 · 0001493152-26-049718

  5. DEFA14A filing

    DEFA14A · 2026-11-03 · 0001493152-26-049716

Show 5 more recent filings
  1. DEF 14A filing

    DEF 14A · 2026-11-03 · 0001493152-26-049715

  2. Regulation FD Disclosure

    Items 7.01, 9.01

    8-K · 2026-10-27 · 0001493152-26-048640

  3. Regulation FD Disclosure

    Items 7.01, 9.01

    8-K · 2026-10-23 · 0001493152-26-048182

  4. Shareholder Director Nominations · Regulation FD Disclosure

    Items 5.08, 7.01, 9.01

    8-K · 2026-10-20 · 0001493152-26-047702

  5. Regulation FD Disclosure

    Items 7.01, 9.01

    8-K · 2026-10-06 · 0001493152-26-045866

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income-13,142,000USD · FY 2025
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

Operating income-14,743,000USD · FY 2025
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

Diluted EPS-0.29USD per share · FY 2025
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD81,760,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

5,208,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

73,365,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

33,131,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

7,434,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

78,066,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

30,892,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

7,367,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

81,544,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

6,031,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

8,327,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

9,537,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Property, Plant and Equipment, NetUSD78,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

99,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

316,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

75,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

122,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

188,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

78,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

132,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

93,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

80,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

146,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

221,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD6,704,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

479,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2024-09-30

3,152,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

4,082,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2025-06-30

2,465,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2024-06-30

3,657,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

3,217,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

1,162,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

3,912,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

3,114,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

2,468,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

2,442,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Inventory, NetUSD——2,907,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

——2,257,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

——584,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

———
Assets, CurrentUSD80,785,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

4,995,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

72,173,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

32,891,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

7,138,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

76,528,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

30,656,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

7,000,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

79,822,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

5,819,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

7,921,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

8,814,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD573,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

609,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

709,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

164,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

628,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

660,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

218,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

603,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

644,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

300,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

152,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

532,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD897,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

114,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

800,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

165,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

174,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

870,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

158,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

235,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

833,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

132,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

260,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

502,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD3,536,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

1,400,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

4,438,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

2,774,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

1,379,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

3,961,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

1,941,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

1,200,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

3,990,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

2,501,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

3,826,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

2,248,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD659,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

168,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

672,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

380,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

161,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

672,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

348,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

145,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

672,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

195,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

118,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

80,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-100,622,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

-87,552,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

-113,384,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

-97,045,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

-84,337,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

-107,757,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

-93,545,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

-81,872,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

-104,086,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

-90,944,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

-79,501,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

-68,761,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD78,224,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

3,808,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2024-09-30

68,927,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

30,357,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2025-06-30

6,055,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2024-06-30

74,105,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

28,951,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2025-03-31

6,167,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2024-03-31

77,554,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

3,530,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

4,501,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

7,289,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Additional Paid in Capital, Common StockUSD178,187,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

91,192,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

181,639,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

127,022,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

90,231,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

181,190,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

122,148,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

87,894,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

180,968,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

94,279,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

83,884,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

75,970,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Liabilities and EquityUSD81,760,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

5,208,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

73,365,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

33,131,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

7,434,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

78,066,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

30,892,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

7,367,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

81,544,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

6,031,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

8,327,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

9,537,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD2,934,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

1,371,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

3,888,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

2,727,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

1,341,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

3,387,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

1,893,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

1,183,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

3,421,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

2,460,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

3,786,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

2,069,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Operating Lease, Liability, CurrentUSD297,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

65,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

326,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

102,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

110,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

324,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

90,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

191,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

296,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

70,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

191,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

283,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Accounts Payable, CurrentUSD509,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

246,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

871,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

503,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

178,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

1,085,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

186,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

96,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

511,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

——116,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD602,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

29,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

550,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

47,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

38,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

574,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

48,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

17,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

569,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

41,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

40,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

179,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD2,128,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

1,060,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

2,691,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

2,122,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

1,053,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

1,978,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

1,617,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

896,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

2,614,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

2,225,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

1,027,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

1,670,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Cash, Cash Equivalents, and Short-term InvestmentsUSD80,158,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

4,338,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

67,367,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

32,674,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

6,462,000
Source

10-Q · 2024-08-14 · 0001493152-24-032031

As of 2024-06-30

72,500,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

30,390,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

6,349,000
Source

10-Q · 2024-05-15 · 0001493152-24-019535

As of 2024-03-31

78,592,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

5,470,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

6,385,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

8,202,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Deferred Tax Liabilities, NetUSD————————191,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

30,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

357,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

114,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, Current———
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

———
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

——————

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD——————12,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

15,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

47,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

91,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

106,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

102,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD————433,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

237,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2025-04-01 to 2025-06-30

222,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

256,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

1,057,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

1,349,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

1,394,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

1,752,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in InventoriesUSD——————1,673,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

—584,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

———
Net Cash Provided by (Used in) Operating ActivitiesUSD——————-5,053,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

-2,874,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

-13,046,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

-8,827,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

-8,533,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

-11,549,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————4,997,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

-24,830,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

-72,384,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

1,537,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

1,973,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

-3,836,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Payments for (Proceeds from) Other Investing ActivitiesUSD——————————-3,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

—
Payments to Acquire Property, Plant, and EquipmentUSD——————108,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

13,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

60,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

25,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

33,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

84,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD———————27,806,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

86,240,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

7,936,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

6,558,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

4,324,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-56,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

102,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

810,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

646,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

-2,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

-11,061,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD—————————171,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

130,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

51,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD———————————1,752,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, and Short-term InvestmentsUSD——80,158,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

4,338,000
Source

10-Q · 2024-11-13 · 0001493152-24-045136

As of 2024-09-30

67,367,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

32,674,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

As of 2025-06-30

72,500,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

As of 2026-03-31

30,390,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

As of 2025-03-31

78,592,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

As of 2025-12-31

5,470,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

As of 2024-12-31

6,385,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

As of 2023-12-31

8,202,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

As of 2022-12-31

Gain (Loss) on Disposition of Property Plant EquipmentUSD——————————-2,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

-5,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Gain (Loss) Related to Litigation SettlementUSD——————————-1,111,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

—
General and Administrative ExpenseUSD——2,690,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2025-07-01 to 2025-09-30

1,240,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2024-07-01 to 2024-09-30

—1,612,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

2025-04-01 to 2025-06-30

—1,562,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

2025-01-01 to 2025-03-31

—4,995,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

4,131,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

5,545,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Marketable Securities, Unrealized Gain (Loss)USD——————222,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

—4,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

59,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

12,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-3,577,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2025-07-01 to 2025-09-30

-3,215,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2024-07-01 to 2024-09-30

-5,627,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

-3,500,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2025-04-01 to 2025-06-30

-3,671,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

-2,601,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

-13,142,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

-11,443,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

-10,740,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

-13,168,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD———————316,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

———-5,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Increase (Decrease) in Accounts Receivable———————
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

—————
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents———
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2025-09-30

—
Source

10-Q · 2025-11-12 · 0001493152-25-021929

As of 2024-09-30

—
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2026-06-30

—
Source

10-Q · 2026-08-11 · 0001493152-26-037009

As of 2025-06-30

——————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Selling, General and Administrative ExpenseUSD————3,684,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

1,612,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2025-04-01 to 2025-06-30

3,029,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

1,562,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

8,460,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

———
Operating Income (Loss)USD——-3,861,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2025-07-01 to 2025-09-30

-3,300,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2024-07-01 to 2024-09-30

-6,188,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

-3,723,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2025-04-01 to 2025-06-30

-4,320,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

-3,021,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

-14,743,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

-11,625,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

-9,855,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

-13,281,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD———————316,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

———-5,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-3,577,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2025-07-01 to 2025-09-30

-3,215,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2024-07-01 to 2024-09-30

-5,627,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

-3,500,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2025-04-01 to 2025-06-30

-3,671,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

-2,601,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

-13,142,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

-11,443,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

-10,740,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

-13,168,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.07
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2025-07-01 to 2025-09-30

-0.2
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2024-07-01 to 2024-09-30

-0.08
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

-0.1
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2025-04-01 to 2025-06-30

-0.05
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

-0.08
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

-0.29
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

-0.73
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

-1.05
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

-1.81
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.07
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2025-07-01 to 2025-09-30

-0.2
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2024-07-01 to 2024-09-30

-0.08
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

-0.1
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2025-04-01 to 2025-06-30

-0.05
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

-0.08
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

-0.29
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

-0.73
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

-1.05
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

—
Weighted Average Number of Shares Outstanding, Basicshares——48,095,384
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2025-07-01 to 2025-09-30

16,471,419
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2024-07-01 to 2024-09-30

67,163,613
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

36,488,014
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2025-04-01 to 2025-06-30

67,158,044
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

31,085,606
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

45,790,362
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

15,644,511
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

10,199,984
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

7,260,344
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——48,095,384
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2025-07-01 to 2025-09-30

16,471,419
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2024-07-01 to 2024-09-30

67,163,613
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

36,488,014
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2025-04-01 to 2025-06-30

67,158,044
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

31,085,606
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

45,790,362
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

15,644,511
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

10,199,984
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

—
Additional Financial Items
Costs and ExpensesUSD———————————4,562,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Gain (Loss) Related to Litigation SettlementUSD——————————-1,111,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

—
General and Administrative ExpenseUSD——2,690,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2025-07-01 to 2025-09-30

1,240,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2024-07-01 to 2024-09-30

—1,612,000
Source

10-Q · 2025-08-12 · 0001641172-25-023206

2025-04-01 to 2025-06-30

—1,562,000
Source

10-Q · 2025-05-14 · 0001641172-25-010277

2025-01-01 to 2025-03-31

—4,995,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

4,131,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

5,545,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Interest Income (Expense), Nonoperating, NetUSD——284,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2025-07-01 to 2025-09-30

85,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2024-07-01 to 2024-09-30

561,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

223,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2025-04-01 to 2025-06-30

649,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

104,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

1,285,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

182,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

228,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

118,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Labor and Related ExpenseUSD———————————2,067,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Other ExpensesUSD—————————239,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

——
Research and Development ExpenseUSD——1,171,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2025-07-01 to 2025-09-30

2,060,000
Source

10-Q · 2025-11-12 · 0001493152-25-021929

2024-07-01 to 2024-09-30

1,861,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

2,111,000
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2025-04-01 to 2025-06-30

1,293,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

1,459,000
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2025-01-01 to 2025-03-31

6,283,000
Source

10-K · 2026-03-26 · 0001493152-26-012935

2025-01-01 to 2025-12-31

6,630,000
Source

10-K · 2025-03-25 · 0001641172-25-000614

2024-01-01 to 2024-12-31

5,724,000
Source

10-K · 2024-03-27 · 0001493152-24-011521

2023-01-01 to 2023-12-31

7,736,000
Source

10-K · 2023-03-31 · 0001493152-23-010223

2022-01-01 to 2022-12-31

Total Revenue—————
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

——
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

—————
Cost of Goods and Services Sold—————
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

——
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

—————
Gross Profit—————
Source

10-Q · 2026-08-11 · 0001493152-26-037009

2026-04-01 to 2026-06-30

——
Source

10-Q · 2026-05-13 · 0001493152-26-022792

2026-01-01 to 2026-03-31

—————

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-284688

S-1/A · 2025-02-10 · 0001493152-25-005688

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

ex99-1.htm · 8-K · 2026-11-16

Exhibit 99.1 Microbot Medical® Files 10-Q and Highlights Key Third Quarter Operating Achievements Company continues to expand commercial presence in the U.S. while it progresses international market entry and opportunities Increased the number of health systems and hospital sites using LIBERTY, while utilization of the LIBERTY System rose 44% compared to the second quarter HINGHAM, Mass., November 16, 2026 - Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LI…

8-K · 2026-11-16 · 0001493152-26-052054

Read attachment ↗
ex99-1.htm · 8-K · 2026-11-05

Exhibit 99.1 Microbot Medical® Strengthens IP Portfolio as it Continues to Establish Infrastructure to Support Future Commercialization Expansion HINGHAM, Mass., November 5, 2026 - Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, today announced that the Canadian Intellectual Property Office (CIPO) granted the Company a patent for an adaptor for coupling a proximal portion of an elongate surgical tool (guidewire, microcathe…

8-K · 2026-11-05 · 0001493152-26-050070

Read attachment ↗
ex99-1.htm · 8-K · 2026-10-27

Exhibit 99.1 Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System ELMNT IR also became the first account on the West Coast, marking a geographic expansion which aligns with the Company’s Full Market Release strategy. The Company believes the OBLs represent a rapidly growing healthcare segment and opportunity as many endovascular procedures are being done outside traditional hospital settings and Ambulatory Surgery Centers. HINGHAM, …

8-K · 2026-10-27 · 0001493152-26-048640

Read attachment ↗
ex99-1.htm · 8-K · 2026-10-23

Exhibit 99.1 Microbot Medical® Attending Key Medical Conference to Engage with Decisionmakers as it Continues to Expand Presence Across the U.S. Opportunity to Connect with Hospital Administrators and Physicians to Foster Expanded Adoption of the LIBERTY System HINGHAM, Mass., October 23, 2026 - Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, today announced that key executives and members of the Company’s commercial tea…

8-K · 2026-10-23 · 0001493152-26-048182

Read attachment ↗
ex99-1.htm · 8-K · 2026-10-20

Exhibit 99.1 Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio The Company now holds 44 issued patents and 49 pending patents globally. Commercialization continues to advance across both U.S. and international markets. HINGHAM, Mass., October 20, 2026 - Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has received several new patent approvals …

8-K · 2026-10-20 · 0001493152-26-047702

Read attachment ↗
ex99-1.htm · 8-K · 2026-10-06

Exhibit 99.1 Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel Medtechnica Ltd., a Leading Medical Device Distributor in Israel, Authorized to Distribute the LIBERTY® Endovascular Robotic System Throughout Israel Microbot Medical is Executing its International Markets Strategy by Engaging with Distributors in Developed Markets to Prepare for Potential Future Market Entry Outside of the U.S. HINGHAM, Mass., October 6, 2026 -- Microbot Medi…

8-K · 2026-10-06 · 0001493152-26-045866

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.